Newly-approved MelaFind® uses breakthrough technology to non-invasively and painlessly see below the skin’s surface and objectively evaluate the three-dimensional morphological disorganization of clinically atypical pigmented skin lesions. MelaFind® uses multi-spectral data capture and sophisticated computer algorithms to automatically acquire and analyze lesion data from under the skin’s surface in order to help dermatologists detect melanoma at its most curable and treatable stages. More information means more informed decisions when making difficult biopsy decisions.
Only MelaFind® sees beneath the skin’s surface to help analyze irregular moles.
MelaFind® is an FDA-approved, clinically tested, non-invasive, painless medical device that sees into and analyzes the skin. It provides more information to your dermatologist – with critical information when deciding to biopsy irregular moles and immediate results in a few easy steps – no waiting, no worrying.